Alnylam Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Alnylam Pharmaceuticals patents 133 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER External link
Filling date: 9 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE External link
Filling date: 9 Sep 2025 Issue date: 27 May 2021
Application
Utility: APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE External link
Filling date: 9 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: OLIGONUCLEOTIDES COMPRISING ACYCLIC AND ABASIC NUCLEOSIDES AND ANALOGS External link
Filling date: 9 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE External link
Filling date: 9 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS External link
Filling date: 9 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 18 Feb 2021
Application
Utility: SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT External link
Filling date: 9 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS External link
Filling date: 9 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 7 Jan 2021
Application
Utility: TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES External link
Filling date: 9 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE External link
Filling date: 9 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: MODIFIED RNAi AGENTS External link
Filling date: 9 Sep 2025 Issue date: 12 Nov 2020
Application
Utility: SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENT COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: ASSAYS AND METHODS FOR DETERMINING EXPRESSION OF THE LECT2 GENE External link
Filling date: 9 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: Dual Targeting siRNA Agents External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: Compositions and Methods for Inhibiting Expression of the PCSK9 Gene External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: HIGH MOBILITY GROUP BOX-1 (HMGB1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES External link
Filling date: 9 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: METHODS AND COMPOSITIONS FOR DETECTING ANTI-DRUG ANTIBODIES External link
Filling date: 9 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: Compositions and Methods for Inhibiting Expression of Transthyretin External link
Filling date: 9 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: THERAPEUTIC COMPOSITIONS External link
Filling date: 9 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITIION OF EXPRESSION OF PROTEIN C (PROC) GENES External link
Filling date: 9 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF SERUM AMYLOID A GENE External link
Filling date: 9 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V External link
Filling date: 9 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: METHODS FOR TREATING OR PREVENTING CONTACT-ACTIVATION PATHWAY-ASSOCIATED DISEASES USING iRNA COMPOSITIONS TARGETING FACTOR XII (HAGEMAN FACTOR) (F12) External link
Filling date: 9 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis External link
Filling date: 9 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE External link
Filling date: 9 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: Methods For Inhibition Of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression External link
Filling date: 9 Sep 2025 Issue date: 28 May 2020
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER External link
Filling date: 9 Sep 2025 Issue date: 7 May 2020
Application
Utility: HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 7 May 2020

Showing 50 to 100 of 133 patents.